Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene
Authors:
- 1 April 2007
- journal article
- case report
- Published by Elsevier in Neuromuscular Disorders
- Vol. 17 (4) , 338-345
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Characterization of recessive RYR1 mutations in core myopathiesHuman Molecular Genetics, 2006
- Frequency and localization of mutations in the 106 exons of theRYR1 gene in 50 individuals with malignant hyperthermiaHuman Mutation, 2006
- Central core disease is due to RYR1 mutations in more than 90% of patientsBrain, 2006
- Functional properties of ryanodine receptors carrying three amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalized lymphocytesBiochemical Journal, 2006
- Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disordersNeuromuscular Disorders, 2005
- Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutationsNeuromuscular Disorders, 2004
- 111th ENMC International Workshop on Multi-minicore Disease. 2nd International MmD Workshop, 9–11 November 2002, Naarden, The NetherlandsNeuromuscular Disorders, 2004
- Effect of Ryanodine Receptor Mutations on Interleukin-6 Release and Intracellular Calcium Homeostasis in Human Myotubes from Malignant Hyperthermia-susceptible Individuals and Patients Affected by Central Core DiseaseJournal of Biological Chemistry, 2004
- A recessive form of central core disease, transiently presenting as multi‐minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 geneAnnals of Neurology, 2002
- A gene mutated in X–linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeastNature Genetics, 1996